Partners in Crime by Conradt, B
 1 
 




Center for Integrated Protein Science Munich – CIPSM, Department Biology II, Ludwig-




Caspases have apoptotic as well as non-apoptotic functions, both of which depend on their 
abilities to cleave proteins at specific sites. What distinguishes apoptotic from non-
apoptotic substrates has so far been unclear. In this issue, Weaver et al. (2017) now provide 
an answer to this crucial question. 
(1181) 
Caspases are cysteine-dependent aspartate-specific proteases that are well known for their 
essential, conserved roles in apoptotic cell death. However, in recent years, it has become clear 
that caspases are involved in processes other than apoptosis. Indeed, the founding member of the 
caspase family, C. elegans CED-3, has now been implicated in processes ranging from neuronal 
regeneration to aging (Nakajima and Kuranaga, 2017). The ced-3 gene was originally identified 
in a genetic screen for mutants in which many of the 131 somatic cells that reproducibly die 
during C. elegans development fail to do so (Ellis and Horvitz, 1986). The subsequent cloning of 
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the ced-3 gene led to the discovery that the gene encodes a protease, and this was the first step 
towards the elucidation of the molecular mechanisms underlying apoptotic cell death (Conradt et 
al., 2016). The current model for how ced-3 promotes apoptosis in C. elegans is that in cells 
‘programmed’ to die, the pro-form of CED-3 (i.e. proCED-3) is converted into the mature, fully 
active CED-3 enzyme, which is composed of two small (p15) and two large (p17) subunits. 
CED-3 activation in this context is triggered by the BH3-only protein EGL-1 and mediated by 
the apoptosome, which is composed of eight subunits of the Apaf1-like protein CED-4. CED-3 
then cleaves various protein substrates at specific sites (C-terminal to the amino acid sequence 
DxxD), thereby either inactivating their anti-apoptotic function or activating their apoptotic 
function, and thus triggering the cellular processes necessary for the controlled dismantling and 
engulfment of the cell. For example, the cleavage and activation by CED-3 of the putative 
transporter CED-8 Xkr is required for the exposure on the cell surface of phosphatidylserine, 
which is critical for the recognition of the apoptotic cell by phagocytes (Chen et al., 2013; Suzuki 
et al., 2013).  
 A few years ago, Min Han and colleagues ‘rediscovered’ the ced-3 gene in a screen for 
mutations that enhance the developmental defects caused by compromised microRNA-induced 
silencing complex (miRISC) function (Weaver et al., 2014). By reducing the stability and/or 
translation of mRNAs, miRISC represses the expression of numerous genes, including the 
heterochronic gene lin-28 (Ambros, 2011). lin-28 encodes an RNA-binding protein that is 
necessary for the timely occurrence of processes that take place specifically during the second 
larval (L2) stage of C. elegans development (Moss et al., 1997). For example, in wild-type 
animals the epidermal seam cells (which are stem cell-like) undergo a specific pattern of cell 
divisions during the L2 stage. Mutations that inactivate lin-28 result in the ‘skipping’ of these 
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cell divisions, and thus a reduction in the number of seam cells in adult animals (the lin-28 loss-
of-function [lf] phenotype). In wild-type animals, miRISC-mediated repression of lin-28 
expression occurs towards the end of the L2 stage, and this is critical for the transition to the L3 
stage and the timely occurrence of L3-specific processes. Inappropriate elevation of LIN-28 
protein levels in the seam cells results in the ‘reiteration’ of the L2-specific cell division patterns 
and an increase in the number of seam cells in adults (the lin-28 gain-of-function [gf] 
phenotype). In their 2014 publication, Han and colleagues demonstrated that the inactivation of 
ced-3 function in a genetic background where miRISC function is compromised greatly enhances 
the lin-28 gf phenotype (Weaver et al., 2014). Furthermore, they showed that LIN-28 protein is a 
substrate of the CED-3 caspase in vitro and that CED-3 proteolytically cleaves LIN-28 at a 
specific site (28DVVD31) to generate a truncated LIN-28 protein that lacks the first 31 amino 
acids. Finally, they presented evidence that ced-3 function is necessary for the efficient loss of 
LIN-28 protein at the L2-L3 transition. Based on these findings, the authors proposed that 
miRISC and CED-3 function redundantly in the repression of lin-28 expression and thereby 
contribute to the robustness of developmental transitions during C. elegans development 
(Weaver et al., 2014). In the current issue of Development Cell, Weaver and colleagues (2017) 
now go one step further in their analysis of this non-apoptotic function of the CED-3 caspase . 
Their findings uncover a mechanism that may represent a general paradigm for the recognition 
and inactivation of non-apoptotic caspase substrates. 
 
The impetus for this most recent report stemmed from two observations that suggested CED-3 
caspase might cooperate with another protein degradation system to reduce the level of LIN-28 
protein at the L2-L3 transition. First, the truncated LIN-28 protein generated by ced-3-dependent 
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cleavage can rescue the lin-28 lf phenotype, and therefore is functional in vivo. For this reason, 
there must be an additional mechanism that leads to reduced LIN-28 activity. Second, the 
truncated LIN-28 protein contains an N-terminal asparagine and, hence, could potentially be 
subject to degradation by the Arg/N-end rule pathway (Varshavsky, 2011). Indeed, Weaver and 
colleagues (2017) now provide in vitro and in vivo evidence that ced-3-dependent cleavage of 
LIN-28 generates an Arg/N-end rule degron. In addition, they demonstrate that, like the loss of 
ced-3, the loss of either ubr-1 or ate-1 greatly enhances the lin-28 gf phenotype of animals in 
which miRISC function is compromised (ubr-1 encodes a UBR-type E3 ubiquitin ligase, and 
ate-1 an arginyltransferase, both of which are required for protein degradation mediated by the 
Arg/N-end rule pathway). Furthermore, they provide genetic evidence that in the context of the 
control of lin-28 expression, the activities of CED-3 caspase and the Arg/N-end rule pathway are 
mutually dependent. This notion is further supported by the demonstration that the UBR-1 and 
ATE-1 proteins physically interact with CED-3 caspase. Based on these findings, Weaver and 
colleagues put forward the model that a protein complex comprising CED-3, UBR-1 and ATE-1 
binds to LIN-28, and this results in ced-3-dependent cleavage of LIN-28 protein at 28DVVD31. 
The truncated LIN-28 protein is then subject to ubr-1- and ate-1-dependent degradation through 
the Arg/N-end rule pathway (Weaver et al., 2017).  
 Are these observations representative of a general phenomenon in C. elegans? It remains 
to be determined whether other non-apoptotic CED-3 substrates are also recognized by the CED-
3, UBR-1, ATE-1 complex instead of being bound by CED-3 alone (as is presumably the case 
for apoptotic CED-3 substrates). And is ‘partnering up’ with components of the Arg/N-end rule 
pathway also utilized by caspases in mammalian cells to recognize non-apoptotic substrates and 
control their levels?  This could well be the case, since Weaver and colleagues (2017) report that 
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several mammalian caspases (including Caspases 1, 3 and 8) interact with human UBR2 protein 
in vitro. Other exciting and important questions also remain to be addressed in the context of C. 
elegans development, and in the context of the control of lin-28 expression. In particular, how is 
the maturation and activation of CED-3 caspase regulated in non-apoptotic cells? And, how is 
the activity of the CED-3, UBR-1, ATE-1 complex controlled? Finally, it is worth noting that 
both the apoptotic function of ced-3 and the anti-apoptotic function of ced-3 in the control of 
developmental transitions were discovered through forward genetic screens. This serves as a 
reminder of the timeless power of unbiased experimental approaches and of genetic models such 
as C. elegans. 
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